15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeutics

João Conde, Alfredo Ambrosone, Yulán Hernandez, Furong Tian, Mark McCully, Catherine C. Berry, Pedro V. Baptista, Claudia Tortiglione, Jesus M. De La Fuente

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

70 Citas (Scopus)

Resumen

Summary RNAi has always captivated scientists due to its tremendous power to modulate the phenotype of living organisms. This natural and powerful biological mechanism can now be harnessed to downregulate specific gene expression in diseased cells, opening up endless opportunities. Since most of the conventional siRNA delivery methods are limited by a narrow therapeutic index and significant side and off-target effects, we are now in the dawn of a new age in gene therapy driven by nanotechnology vehicles for RNAi therapeutics. Here, we outlook the "do's and dont's" of the inorganic RNAi nanomaterials developed in the last 15 years and the different strategies employed are compared and scrutinized, offering important suggestions for the next 15.

Idioma originalInglés
Páginas (desde-hasta)421-450
Número de páginas30
PublicaciónNano Today
Volumen10
N.º4
DOI
EstadoPublicada - ago. 2015
Publicado de forma externa

Huella

Profundice en los temas de investigación de '15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeutics'. En conjunto forman una huella única.

Citar esto